Enliven Therapeutics, Inc. · NASDAQ:ELVN

Orbimed Advisors LLC sold 281,408 Enliven Therapeutics, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 17, 2026

On Jun 15, 2026, Orbimed Advisors LLC (10% owner) sold 281,408 Enliven Therapeutics, Inc. shares at US$45.02 for US$12.7M, leaving 7,388,902 shares. Filed Jun 17, 2026 (Form 4).

Sold
281,408 shares
Price
US$45.02
Value
US$12.7M
Holding after
7,388,902 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockSale9,086US$45.02245,728Indirect
Jun 15, 2026Common StockSale272,322US$45.027,388,902Indirect

Source

View original at SEC

Related